Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?

Martina Severa, Cinthia Farina, Marco Salvetti, Eliana Marina Coccia

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)1459
JournalFront. Immunol.
Publication statusPublished - 2020


  • Antiviral Agents/therapeutic use
  • Betacoronavirus/drug effects
  • Coronavirus Infections/drug therapy
  • Drug Repositioning/methods
  • Humans
  • Immunologic Factors/therapeutic use
  • Interferon-beta/therapeutic use
  • Multiple Sclerosis/drug therapy
  • Pandemics
  • Pneumonia, Viral/drug therapy
  • Virus Replication/drug effects

Cite this